Finally, Some Good News for Tesla Investors

Tesla’s unsupervised robotaxi fleet grew to 26 vehicles by the end of April from 9 at the start of the month, with additional preparations underway in several U.S. cities. Management signaled that a large-scale ramp-up is unlikely before 2027 and depends on FSD V15, which is expected no earlier than late 2026 to early 2027. Separate progress on supervised FSD approval in the Netherlands and possible EU-wide approval could further improve sentiment through 2026.

Analysis

The key second-order effect is not the small robotaxi fleet itself, but the reset in expectations. When a narrative goes from “near-term scale” to “multi-year build,” every incremental deployment becomes a positive surprise, which can mechanically support multiple expansion even before material revenue exists. That makes TSLA more sensitive to progress milestones and regulatory headlines than to current operating economics, and it also shifts the market’s focus from adoption speed to proof-of-safety cadence.

The real gating item is software architecture, not fleet logistics. If a materially better stack is delayed into 2027, then the equity is effectively trading on a long-dated option with intermittent catalysts; that favors sharp sentiment spikes followed by air pockets when timelines slip. Conversely, any evidence of faster EU approvals or additional city launches can lift confidence because it lowers perceived regulatory friction and broadens the addressable pool for supervised FSD first, then unsupervised deployment later.

Competitively, the slower ramp is a mixed bag: it reduces near-term threat to ride-hailing incumbents and autonomous peers, but it also gives Tesla more time to collect real-world data while competitors burn capital. The market may be underappreciating that a slower, safer rollout can be bullish if it preserves optionality and reduces headline risk; what matters is not speed alone, but whether Tesla can avoid a safety event that would set the narrative back by quarters.

The contrarian read is that the stock may already be positioned for disappointment, not success. If so, the next 6-12 months are less about proving autonomy and more about proving cadence: more geographies, more approvals, and fewer operational embarrassments. That makes TSLA vulnerable to any delay in V15, but also attractive for tactical longs into approval or expansion announcements because sentiment leverage is high relative to fundamental contribution today.

Key Decisions for Investors

• Maintain a tactical long TSLA bias into incremental robotaxi or EU approval headlines; use 3-6 month call spreads rather than outright stock to limit drawdown if V15 timing slips.
• If TSLA rallies on sentiment without a confirmed V15 delivery window, fade strength with a short-dated collar or small short against strength; reward/risk skews poorly once the market prices 2026 acceleration that may not arrive.
• Pair trade: long TSLA / short a basket of high-multiple autonomy-adjacent names that need near-term commercialization, on the view Tesla’s incremental progress is more credible than peers’ aspirational timelines.
• Use any confirmed EU-wide or major-country FSD approval as a catalyst to add exposure for a 1-2 quarter trade; the market is likely to overreact to regulatory breadth because it validates global scalability before U.S. unsupervised expansion.
• Avoid treating the current robotaxi fleet as a revenue model; position size should reflect option value, not cash flow, until V15 timing is actually nailed down.